Basel Medical BMGL

NASDAQ BMGL
$0.68 -1.25 (-64.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Basel Medical (BMGL) stock price is $0.68, down 64.56% on the day, as of Nov 11, 2026. It has a market cap of $3.05Mn, and is classified in the Healthcare Services industry (Healthcare sector).

Key Stats
Market Cap3.05 Mn
P/E-5.24
FCF (Yr)-723,775.00
ROA (Yr)-7.59
EV to EBIT4.46
Net Income (Yr)-1.25 Mn
Enterprise Value-2.75 Mn
Add ratio to table…

About

Basel Medical Group Ltd is a business company incorporated in the British Virgin Islands that operates medical clinics in Singapore providing a broad range of healthcare services. The group delivers general and subspecialized orthopedic care including trauma sports medicine spine surgery joint replacement and minimally invasive procedures. It also offers neurosurgical treatments health screening mental health women’s health and general practice services. Its facilities are…

Read more ↓
Sector: Healthcare Sector rationale Basel Medical Group operates medical clinics providing a wide range of patient care services, including orthopedic care, neurosurgery, and general practice. Its revenue is derived from medical consultations, diagnostic tests, and surgical procedures, which are core activities of the Healthcare sector. Industries: Healthcare Services Healthcare Services Primary Basel Medical Group Ltd operates a network of medical clinics in Singapore providing outpatient services including general practice, orthopedic care, neurosurgical treatments, and mental health services. Revenue is generated from fees for medical consultations, diagnostic tests, and therapeutic treatments delivered in these clinic settings. Medical Devices Medical Devices Secondary The company earns income from the sale of prescribed orthopedic devices to its patients, which constitutes a distinct product-based revenue stream alongside its service fees. Classified using BQ-MICS CIK: 0002004489

Products and services [axis] Breakdown of Revenue (2026)

History

Timing of transfer of goods or services [axis] Breakdown of Revenue (2026)

History
Peer percentiles

How Basel Medical ranks

Ranked against the 104 companies in Healthcare Providers58 metrics · as of Nov 11, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −5.24xMedian 22.0x 27th
  • P/FCFNegative free cash flow −4.22xMedian 20.7x 21st
  • P/Operating cash flow —Median 14.9x No data —
  • P/S 0.24xMedian 1.27x 81st
  • P/B 0.87xMedian 2.73x 75th
  • P/Tangible book 0.87xMedian 4.02x 79th
  • EV/EBITDA —Median 14.1x No data —
  • EV/EBIT —Median 19.0x No data —
  • EV/Revenue —Median 1.63x No data —
  • EV/FCF —Median 24.7x No data —
  • EV/Operating cash flow —Median 18.8x No data —
  • PEG (3Y EPS CAGR) —Median 0.84 No data —
Peer group

Peer Comparison

Companies in the Healthcare Services
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HCA HCA Healthcare, Inc. 106.37 Bn15.971.3550.49 Bn
2 NTRA Natera, Inc. 45.03 Bn-272.7915.480.08 Bn
3 LH Labcorp Holdings Inc. 30.12 Bn29.972.066.03 Bn
4 DGX Quest Diagnostics Inc 28.44 Bn25.182.405.55 Bn
5 GH Guardant Health, Inc. 20.93 Bn-43.0516.36-
6 BTSG BrightSpring Health Services, Inc. 14.41 Bn36.580.952.18 Bn
7 TEM Tempus AI, Inc. 14.27 Bn-77.149.45-
8 BMGL Basel Medical Group Ltd 0.00 Bn-5.240.240.01 Bn